Cardiac Electronic Devices: Future Directions and Challenges

Agnieszka Kotalczyk,1,2 Zbigniew Kalarus,2 David Justin Wright,1 Giuseppe Boriani,3 Gregory Y H Lip1,2 1Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK; 2Department of Cardiology, Congenital Heart Diseases and Electrotherapy,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kotalczyk A, Kalarus Z, Wright DJ, Boriani G, Lip GYH
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/0f50ec123eb8433e8f4f1a10de49c5f8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Agnieszka Kotalczyk,1,2 Zbigniew Kalarus,2 David Justin Wright,1 Giuseppe Boriani,3 Gregory Y H Lip1,2 1Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK; 2Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland; 3Cardiology Division, Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, ItalyCorrespondence: Gregory Y H Lip Email gregory.lip@liverpool.ac.ukAbstract: Cardiovascular implantable electronic devices (CIEDs) are essential management options for patients with brady- and tachyarrhythmias or heart failure with concomitant optimal pharmacotherapy. Despite increasing technological advances, there are still gaps in the management of CIED patients, eg, the growing number of lead- and pocket-related long-term complications, including cardiac device–related infective endocarditis, requires the greatest care. Likewise, patients with CIEDs should be monitored remotely as a part of a comprehensive, holistic management approach. In addition, novel technologies used in smartwatches may be a convenient tool for long-term atrial fibrillation (AF) screening, especially in high-risk populations. Early detection of AF may reduce the risk of stroke and other AF-related complications. The objective of this review article was to provide an overview of novel technologies in cardiac rhythm–management devices and future challenges related to CIEDs.Keywords: cardiovascular implantable electronic devices, CIEDs, pacemaker, implantable cardioverter–defibrillator, cardiac resynchronization therapy, remote monitoring, wearable technology